(window.webpackJsonp=window.webpackJsonp||[]).push([[115],{862:function(v,_,t){"use strict";t.r(_);var r=t(12),n=Object(r.a)({},(function(){var v=this,_=v.$createElement,t=v._self._c||_;return t("ContentSlotsDistributor",{attrs:{"slot-key":v.$parent.slotKey}},[t("p",[v._v("儿童脓毒症休克血管活性药物")]),v._v(" "),t("table",[t("thead",[t("tr",[t("th",[v._v("药物")]),v._v(" "),t("th",[v._v("剂量")]),v._v(" "),t("th",[v._v("备注")])])]),v._v(" "),t("tbody",[t("tr",[t("td",[v._v("多巴胺")]),v._v(" "),t("td",[v._v("5-10 μg/(kg·min)")]),v._v(" "),t("td",[v._v("根据血压监测调整剂量，最大量不宜超过 20")])]),v._v(" "),t("tr",[t("td",[v._v("去甲肾上腺素")]),v._v(" "),t("td",[v._v("0.05-0.3 μg/(kg·min)")]),v._v(" "),t("td",[v._v("暖休克或有多巴胺抵抗时首选。"),t("br"),v._v("对儿茶酚胺反应的个体差异很大，"),t("br"),v._v("用药要注意个体化原则。"),t("br"),v._v("若有 α 受体敏感性下调，"),t("br"),v._v("出现对去甲肾上腺素的抵抗，"),t("br"),v._v("有条件可试用血管紧张素或精氨酸血管加压素，"),t("br"),v._v("这类药物发挥作用不受 α 受体的影响。")])]),v._v(" "),t("tr",[t("td",[v._v("肾上腺素")]),v._v(" "),t("td",[v._v("0.05-2 μg/(kg·min)")]),v._v(" "),t("td",[v._v("冷休克或有多巴胺抵抗时首选")])]),v._v(" "),t("tr",[t("td",[v._v("多巴酚丁胺")]),v._v(" "),t("td",[v._v("5-10 μg/(kg·min)")]),v._v(" "),t("td",[v._v("最大量不宜超过 20 μg/(kg・min)。"),t("br"),v._v("对多巴酚丁胺抵抗，可用肾上腺素。"),t("br"),v._v("若存在儿茶酚胺抵抗，可选用氨力农、米力衣。")])]),v._v(" "),t("tr",[t("td",[v._v("硝普钠")]),v._v(" "),t("td",[v._v("0.5-8 μg/(kg·min)")]),v._v(" "),t("td",[v._v("心功能障碍严重且又存在高外周阻力的患儿，"),t("br"),v._v("在液体复苏及应用正性肌力药物的基"),t("br"),v._v("础上可使用半衰期短的血管扩张剂")])])])])])}),[],!1,null,null,null);_.default=n.exports}}]);